# SUMATRIPTAN; NAPROXEN SODIUM
> **ANDA090753** · Abbreviated New Drug Application (Generic) · Sponsor: PAR PHARM · Approved 2013-11-29
## Drug
- **FDA Application Number:** ANDA090753
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUMATRIPTAN; NAPROXEN SODIUM
- **Generic name:** Sumatriptan
- **Active ingredients:** SUMATRIPTAN; NAPROXEN SODIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** PAR PHARM
- **First approval:** 2013-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090753)
---
*AI Analytics · CC0 1.0*